Thank you for registering!
Thank you for your interest in sharing your experience with Optune Gio. A representative will be in contact with you in the next 5–7 business days.
For more information and resources, visit OptuneGio.com.
Thank you for your interest in sharing your experience with Optune Gio. A representative will be in contact with you in the next 5–7 business days.
For more information and resources, visit OptuneGio.com.
Optune Gio is a wearable, portable, FDA-approved device indicated to treat a type of brain cancer called glioblastoma multiforme (GBM) in adult patients 22 years of age or older.
If you have newly diagnosed GBM, Optune Gio is used together with a chemotherapy called temozolomide (TMZ) if:
If your tumor has come back, Optune Gio can be used alone as an alternative to standard medical therapy if:
Optune Gio is not for everyone. Talk to your doctor if you have:
Do not use Optune Gio if you are pregnant or are planning to become pregnant. It is not known if Optune Gio is safe or effective during pregnancy.
Optune Gio should only be used after receiving training from qualified personnel, such as your doctor, a nurse, or other medical staff who have completed a training course given by Novocure®, the maker of Optune Gio.
Most common side effects of Optune Gio when used together with chemotherapy (temozolomide, or TMZ) were low blood platelet count, nausea, constipation, vomiting, tiredness, scalp irritation from the device, headache, seizure, and depression. The most common side effects when using Optune Gio alone were scalp irritation (redness and itchiness) and headache. Other side effects were malaise, muscle twitching, fall and skin ulcers. Talk to your doctor if you have any of these side effects or questions.
Please click here for the Optune Gio Instructions For Use (IFU) for complete information regarding the device’s indications, contraindications, warnings, and precautions.